Quality of care in patients with inflammatory bowel disease from a public health center in Brazil

doi:10.12998/wjcc.v10.i33.12184

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3625)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

176

WORD

HTML

1406

Tables (1-6)

185

Sum=1803

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

343

Download

1421

Sum=1764

Nov 26, 2022 (publication date) through Dec 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Nov 26, 2022; 10(33): 12184-12199
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12184

Table 5 Clinical-, quality of life-, and psychological-related variables and Quality of Care Through the Eyes of Patients with Inflammatory Bowel Disease total care in patients with inflammatory bowel disease

	Correlation co-efficient (R)	P value
Age (yr)	-0.0080	0.9240
Female gender	0.1647	0.0581
Family income (BRL)¹	-0.0060	0.9480
Time since diagnosis (yr)	0.0770	0.3760
Disease (ulcerative colitis vs Crohn’s disease)	-0.2467	0.0042
CDAI (points)	-0.0320	0.7920
Partial Mayo score (points)	-0.0630	0.6200
Disease activity (no vs yes)	-0.0284	0.7454
Medication in use (no vs yes)
Mesalazine	-0.1702	0.0501
Azathioprine	0.1032	0.2369
Corticosteroid	-0.0567	0.5169
Infliximab	0.2223	0.0101
Adalimumab	-0.0223	0.7988
Certolizumab	0.02904	0.7400
Previous hospitalization (no vs yes)	0.1364	0.1172
Previous surgery (no vs yes)	0.1179	0.1762
Psychological monitoring (no vs yes)	-0.0294	0.7366
Infusion center consultation	0.1577	0.0698
Time of travel to the IBD center (h)	0.0090	0.9190
Waiting time for consultation (h)	-0.2670	0.0040
IBDQ score (points)
Bowel function	0.0790	0.3660
Systemic symptoms	0.1560	0.0740
Social function	0.0020	0.9820
Emotional status	0.0200	0.8220
Total score	0.0600	0.4970
SF-36 Questionnaire (points)
Physical aspects	0.0980	0.2620
Physical function	0.0830	0.3430
Bodily pain	-0.0630	0.4700
General health	-0.0020	0.9840
Mental health	0.0760	0.3840
Vitality	0.1040	0.2340
Emotional aspects	0.1200	0.1700
Social function	-0.0200	0.8190
Total score	0.1040	0.2340
HADS Anxiety (points)	-0.0750	0.3930
HADS Depression (points)	-0.0600	0.4990
Self-esteem scale (points)	0.0820	0.3490

¹BRL: Brazilian currency.

Correlation co-efficient (R) values determined via Pearson’s correlation test. QUOTE-IBD: Quality of Care Through the Eyes of Patients with Inflammatory Bowel Disease; CDAI: Crohn’s Disease Activity Index; IBDQ: Inflammatory bowel disease questionnaire; SF-36: 36-Item Short-Form Health Survey; HADS: Hospital Anxiety and Depression Scale.

Citation: Takamune DM, Cury GSA, Ferrás G, Herrerias GSP, Rivera A, Barros JR, Baima JP, Saad-Hossne R, Sassaki LY. Quality of care in patients with inflammatory bowel disease from a public health center in Brazil. World J Clin Cases 2022; 10(33): 12184-12199
URL: https://www.wjgnet.com/2307-8960/full/v10/i33/12184.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i33.12184